Tao Zhang, Xinrui Ma, Muyun Xu, Jinghua Cai, Jianhua Cai, Yanguang Cao, Zhihao Zhang, Xin Ji, Jian He, German Oscar Fonseca Cabrera, Xuedan Wu, Weiling Zhao, Zhanhong Wu, Jin Xie, Zibo Li
PURPOSE: Accumulating evidence suggests that neurotensin (NTS) and neurotensin receptors (NTSRs) play key roles in lung cancer progression by triggering multiple oncogenic signaling pathways. This study aims to develop Cu-labeled neurotensin receptor 1 (NTSR1)-targeting agents with the potential for both imaging and therapeutic applications. METHOD: A series of neurotensin receptor antagonists (NRAs) with variable propylamine (PA) linker length and different chelators were synthesized, including [64 Cu]Cu-CB-TE2A-iPA-NRA ([64 Cu]Cu-4a-c, i = 1, 2, 3), [64 Cu]Cu-NOTA-2PA-NRA ([64 Cu]Cu-4d), [64 Cu]Cu-DOTA-2PA-NRA ([64 Cu]Cu-4e, also known as [64 Cu]Cu-3BP-227), and [64 Cu]Cu-DOTA-VS-2PA-NRA ([64 Cu]Cu-4f)...
May 21, 2024: European Journal of Nuclear Medicine and Molecular Imaging